Nicotine Replacement Therapy Sampling for Smokers in the Community
Not Applicable
Recruiting
- Conditions
- Tobacco Smoking
- Registration Number
- NCT05881083
- Lead Sponsor
- The University of Hong Kong
- Brief Summary
The aim of this clinical trial is to test the effectiveness of 1-week nicotine replacement therapy sampling delivered by lay counsellors in promoting smoking cessation in smokers in the community.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1014
Inclusion Criteria
- Hong Kong residents aged 18 years or above
- Smoke cigarette or heated tobacco product or e-cigarette daily in the past 3 months
- Exhaled carbon monoxide level ≥4 part per million or a positive salivary cotinine test
- Able to communicate in and read Chinese
- Have a local contact number
Exclusion Criteria
- Participating in another smoking cessation programme or using any smoking cessation drug or nicotine replacement therapy
- Pregnant or breastfeeding
- Recent (≤ 2 weeks) angina, cardiac arrhythmia or heart attacks
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Biochemically validated tobacco abstinence 6 months Verified by a negative salivary cotinine test
- Secondary Outcome Measures
Name Time Method Biochemically validated tobacco abstinence 3 months Verified by a negative salivary cotinine test
Self-reported 7-day point-prevalence tobacco abstinence 6 months Self-reported use of nicotine replacement therapy product 6 months Self-reported use of smoking cessation service 6 months Self-reported 24-hour quit attempt 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie nicotine replacement therapy efficacy in smoking cessation?
How does 1-week nicotine replacement therapy sampling compare to standard cessation interventions in community settings?
Which biomarkers are associated with successful smoking cessation using nicotine replacement therapy?
What are the potential adverse events of nicotine replacement therapy when administered by lay counsellors?
Are there combination approaches involving nicotine replacement therapy and behavioral interventions for tobacco smoking cessation?
Trial Locations
- Locations (1)
Community sites
🇭🇰Hong Kong, Hong Kong
Community sites🇭🇰Hong Kong, Hong KongTzu Tsun LukContact